Med-IQ partners with JDRF on T1D education
BALTIMORE (PRWEB) October 10, 2019 -- Med-IQ, Inc., the leading provider of clinical and risk management education, consulting services, and quality improvement solutions, announced that it has partnered with JDRF, the leading global organization funding type 1 diabetes (T1D) research, to provide a comprehensive educational initiative on T1D for clinicians, Type 1 Diabetes: The State of Affairs.
In the United States, approximately 1.25 million individuals have T1D, which includes about 200,000 youth and more than 1 million adults. Among these individuals, only 17% of youth and 21% of adults are reaching their HbA1c goals.
“We are excited to partner with Med-IQ to bring this education to clinicians,” said Sydney Yovic, Chief of Staff at JDRF. “This education supports JDRF’s mission to help improve lives today and tomorrow by accelerating life-changing breakthroughs to cure, prevent, and treat T1D and its complications.”
Type 1 Diabetes: The State of Affairs focuses on the comprehensive care of T1D and incorporates a multifaceted approach that includes the following components:
• Webcasts—This webcast series focuses on providing the latest information in T1D management, including diabetes technologies, adjunctive therapies, and psychosocial care, to help improve patient engagement and outcomes.
• Live workshops—Designed for primary care clinicians, this live workshop series provides an interactive forum led by expert faculty and examines real-life case examples. Upcoming workshops will be held on October 25th in San Francisco, CA, and Hartford, CT, and November 15th in Tampa, FL.
• E-brief resources—These short resources address diabetes distress, patient assessment, and solutions for reducing and managing symptoms.
“Technological advances and new therapies continue to emerge. With the incidence of T1D expected to increase to 5 million people by 2050, it is imperative that primary care clinicians, pharmacists, and certified diabetes educators stay up-to-date on all aspects. This educational series is a great step, and we are proud to work with JDRF on this important initiative.” –Allison Gardner, Vice President of Education Strategy and Content
This activity is funded in part by JDRF and The Leona M. and Harry B. Helmsley Charitable Trust and supported by an educational grant from Novo Nordisk, Inc.
About Med-IQ
Med-IQ empowers individuals at every level of the healthcare delivery system with the knowledge they need to continuously improve provider performance and patient outcomes. Med-IQ has delivered unique educational experiences and services across the country and around the world, has been extensively published, and is proud to be one of the most award-winning accredited medical education providers in the United States.
About JDRF
JDRF is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent, and treat T1D and its complications. To accomplish this, JDRF has invested more than $2.2 billion in research funding since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers throughout the United States and our six international affiliates are dedicated to advocacy, community engagement, and our vision of a world without T1D. For more information, please visit jdrf.org or follow us on Twitter: @JDRF.
Adam Glazer, Med-IQ, http://www.coverys.com, +1 (610) 363-5863, [email protected]
Share this article